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ntiviral Therapy for emerging and re-emerging medically
mportant viral pathogensusinghighlypuriﬁednatural product
ompounds
.J.H. Chu
National University of Singapore, Singapore, Singapore
Background: Dengue virus (DENV) is a mosquito-borne virus
hat causes a spectrum of human diseases ranging from mild
engue fever to dengue hemorrhagic fever and dengue shock syn-
rome in severe cases. The current lack of effective anti-viral or
accine against these viruses leave the human populations around
he world at high risk of infection by these viral pathogens.
Methods: In order to identify potential antiviral agents against
ENV, we performed high-throughput cell-based screening on
ighly puriﬁed natural products library. Among the screening hits,
elected compounds which displayed 50-75% inhibition against
ENV2 were validated using secondary assays. Time-of-addition
tudies, dose-dependent assays, quantitative RT-PCR, Western Blot
nd ultrastructural imaging were conducted in an attempt to elu-
idate the potential antiviral mechanisms of narasin.
Results: The ionophore, narasin was selected for detailed anal-
sis due to its strong inhibitory proﬁle against DENV infection with
inimal cytotoxicity (CC50 > 1000 M). A dose-dependent study
evealed narasin to have an IC50 of less than 1 M against all four
erotypes of DENV. Time-of-addition studies of narasin-treated,
ENV2-infected Huh-7 cells suggested narasin to be involved in
nhibiting the post-entry stages of viral replication during DENV
nfection. Quatitative RT-PCR studies showednodifferences in viral
NA levels between narasin-treated and control DENV2-infected
ells. Proteomic and ultrastructural analyses further revealed the
ntiviral mechanism of narasin as likely to be associated with the
peciﬁc disruption of viral protein synthesis and not the host pro-
ein synthesis processes.
Conclusion:Narasinwas identiﬁed and characterized as a novel
gent that inhibits DENV replication through non-cytotoxic mech-
nisms thus indicating its potential to be further developed as a
herapeutic anti-DENV agent.
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engue virus-induced antibodies against thrombin and inhibit
ts activity
.-C. Chuang1,∗, T.-M. Yeh2
National Cheng Kung University, Tainan city, Taiwan, R.O.C
National Cheng Kung University, Tainan, Taiwan, R.O.CBackground: Dengue virus (DENV) infection may result in
evere dengue hemorrhagic fever and shock syndrome (DHF/DSS),
eading to hemorrhage, vascular permeability increase and death.nfectious Diseases 16S (2012) e2–e157
However, the pathogenic mechanism of DHF/DSS is unclear.It has
been shown that DENV shares amino acid sequence homology
with several coagulation and ﬁbrinolysis-related factors such as
thrombin and plasminogen (Plg), respectively. In this study, we
investigated the role of DENV-induced antibodies in thrombin
activity.
Methods: Thrombin afﬁnity-puriﬁed antibodies (PAb) from
DENV hyperimmune rabbit sera was used for detecting the effect
on thrombin activity by using chromogenic, thrombin time, and
ﬁbrin formation assays. The effect of PAb on Plg activation was
determined by chromogenic, ﬁbrin clot lysis assay. In in vivo study,
mice were injected PAb or control rabbit Ig and analyzed thrombin
activity and plasmin activity in platelet poor plasma (PPP).
Results: We found PAb from DENV hyperimmune rabbit sera
couldnot onlybind toDENV,human (pro-)thrombin, but also cross-
react to humanPlg. Furthermore, besides to the enhancement of Plg
activation, PAb could inhibit thrombin activity as determined by
chromogenic, thrombin time, and ﬁbrin formation assays. In PAb
injected mice, thrombin activity were decreased in PPP whereas
plasmin activity were increased. Moreover, the level of D-Dimer
also increased in mice PPP when in the presence of PAb.
Conclusion: Taken together, these results suggest DENV infec-
tion could induce autoantibodies which can inﬂuence thrombin
activity and Plg activation and contribute to hemorrhage in
DHF/DSS.
http://dx.doi.org/10.1016/j.ijid.2012.05.184
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Dengue virus nonstructural protein 1 binds to human endothe-
lial cells and induces cytokine and chemokine production
C.-D. Ciou ∗, T.-M. Yeh
National Cheng Kung University, Tainan, Taiwan, R.O.C
Background: Dengue virus (DENV) is the most common
mosquito-borne virus,which can causemild dengue fever or severe
dengue hemorrhagic fever (DHF) and shock syndrome (DSS). Vas-
cular leakage is one of the hallmarks of DHF/DSS. However, the
mechanism to cause the vascular permeability increase during
DENV infection is still unclear.Denguevirusnonstructural protein1
(NS1) is a highly conserved glycoproteinwhich can be secreted into
blood circulation. The possible effects of secreted NS1 on human
endothelial cells was studied.
Methods: To test the binding activity of NS1 to HMEC-1, we
use ELISA and immunoﬂuscent staining assay. To examine the
chemokine and cytokine production of HMEC-1, HMEC-1 cells
were incubated with NS1 and the supernatants were collected for
cytokine and chemokine ELISA assays.
Results: In this study, we found that recombinant NS1 can
bind to human microvascular endothelial cell line-1 (HMEC-1)
as demonstrated by ELISA. In addition, immunoﬂuscent staining
showed that cell-bound NS1 entered into HMEC-1 cytosol 3 h after
incubation. Furthermore, the secretion of cytokine and chemokine
production, such as macrophage inhibitory factor and monocyte
chemotactic protein-1 from NS1-treated endothelial cells were
increased in a time-dependent manner.
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the response to alpha IFN in patients with chronic HCV infection,
especially those with a low viral load.
http://dx.doi.org/10.1016/j.ijid.2012.05.18715th ICID Abstracts / International Journ
Conclusion: These results suggest the binding of secretedDENV
S1 toendothelial cellsmay induce theproinﬂammatory responses
hich may contribute to the vascular leakage in DHF/DSS.
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olecular characterization of dengue virus from Nepal
.P. Dumre1,∗, K. Na-Bangchang1, V. Eursitthichai1, V. Viyanant1,
. Grams1, G. Shakya2, C. Klungthong3, A.Nisalak3, S. Fernandez3
Thammasat University, Faculty of Allied Health Sciences,
athumthani, 12121, Thailand
National Public Health Laboratory, Kathmandu, Nepal
Armed Forces Research Institute of Medical Sciences, Bangkok,
hailand
Background:Dengue is a global health problem and its expand-
ng endemicity towards new territories is a serious concern.
elatively a new disease in Nepalese context, dengue abruptly
ppeared as massive outbreak in 2010, merely four years after its
rst introduction. We report the ﬁrst phylogenetic relationship of
he dengue virus type 1 (DENV-1) strains from Nepal based on the
omplete envelop (E) gene sequences.
Methods: During 2010 outbreak, specimens of 1215 clinical
engue cases from central and western Nepal were tested for
gG/IgM by enzyme linked immuno-sorbent assay (ELISA). Main-
aining the original proportion of ELISA positive and negative
ases (approximately 1:2), 282 specimens (about one-fourth) were
elected by random sampling and further analyzed by reverse
ranscription-polymerase chain reaction (RT-PCR). Complete E
ene (1485bp) sequencing of DENV-1 strains was performed and
hylogenetic tree of Nepalese strains was created together with 38
lobal E gene sequences of DENV-1 retrieved from GenBank.
Results: Of 1215 clinical cases, 29.5% (359) and 70.5% were
ound dengue positive and negative respectively (ratio about 1:2)
y ELISA. Out of 282 sampled for molecular investigation, RT-PCR
etected 90 (31.9%) cases including 44 (15.6%) cases previously
egative by ELISA. Detection rate increased to 45.4% (128/282)
ith the combination of ELISA and RT-PCR. All four serotypes were
onﬁrmed with DENV-1 as the major one (64.4%) responsible for
his outbreak. Phylogenetic analysis of the E gene sequences of 32
ENV-1 strains from Nepal clustered into genotype V. Nepalese
ENV-1strains showedclose similaritywith the recent strains from
ndia and Singapore.
Conclusion:Over dependency on single serological test (mostly
apid) has led to underestimation of dengue burden in the coun-
ry. Moreover, co-circulation of all serotypes possesses a threat for
evere dengue outbreaks in the future. Due to the lack of dengue
equence data from Nepal, we could not shape the exact evolution-
ry dynamics and origin of the virus in the country. Nevertheless,
e have generated nucleotide sequence database for better under-
tanding of molecular epidemiology in the country. India may be
he origin of Nepalese dengue virus strains based on the close
enetic similarity observed and extensive cross-border activities.
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Endogenous interferon-gamma response in chronic hepatitis C
Egyptian patients treated with peginterferon plus ribavirin
M. El Zowalaty ∗, R. Sadeq, H. Mohtady, N. Al Badawy, S. Ibrahem
Zagazig University, Zagazig, Egypt
Background: Hepatits C virus (HCV) infections remains an
increasingly prevalent and emergent health problem worldwide
that causes awide spectrum of liver diseases. Combination therapy
with pegylated interferon (peginterferon) and ribavirin is currently
recognized as the standard treatment of chronic hepatitis C. Several
immunologicalmechanismsare involved in the courseof treatment
of HCV via interferons. Data are rare in the literature on the role of
endogenous interferon gamma in Egyptian patients with chronic
hepatitis C treated with pegylated interferon and ribavirin ther-
apy. The present study was thus conducted to evaluate the role
of endogenous IFN in the response of chronic hepatitis C (CHC)
patients following treatment with pegylated plus ribavirin.
Methods: Forty patients with chronic hepatitis C (CHC) infec-
tionwere included in the study. Twenty healthy blood donorswere
usedashealthy control.Humanperipheral bloodmononuclear cells
(PBMCs)werepreparedandcultured. IFN secretion fromPBMC/ml
was determined in 24 hr culture supernatants, using standard pro-
tocols for sandwich enzyme linked immunosorbant assay (ELISA).
The biallelic G/T polymorphism in the promoter region of MxA at
position – 88 from the transcription start site [17] was genotyped
using restriction fragment length polymorphism (RFLP).
Results: It was found that enhanced IFN production would be
predicted to favor HCV clearance. Our ﬁnding that the magnitude
of pretreatment of interferon alpha (IFN)-driven IFN responses
correlates with initial response to therapy is certainly consistent
with this prediction. In addition, our ﬁndings suggested that the
single nucleotidepolymorphism (SNP) of theMxAgene is oneof the
important host factors that independently inﬂuences the response
to IFN in patients with CHC infection, especially those with a low
viral load.
Conclusion: In conclusion, enhanced IFN productionwould be
predicted to favor HCV clearance. Our ﬁnding that the magnitude
of pretreatment of alpha IFN-driven IFN responses correlateswith
initial response to therapy is certainly consistent with this pre-
diction. Our ﬁndings suggested that the SNP of the MxA gene is
one of the important host factors that independently inﬂuences
